image description

Forest Labs to buy anti-arrhythmia drug from Blue Ash Therapeutics

Blue Ash Therapeutics
MedCity News, April 19, 2011
Cincinnati-based Blue Ash Therapeutics has reached an agreement in which Forest Laboratories will purchase the rights to an anti-arrhythmia drug the Ohio firm has been developing.

Smooth landings for Israelis in Ohio

Sensible Medical
Israel 21c, January 12, 2011
With more clinical trials by Israeli biomed firms being held in Ohio than in any other state, it’s clear that its priority to woo Israel businesses is bearing fruit.

CardioInsight Technologies Inc. strikes deal with Japanese distributor

Crain’s, January 6, 2011
CardioInsight Technologies Inc. has struck a deal with a Japanese distributor that will invest in the Cleveland-based company and work to commercialize its medical imaging technology in Japan.

NI Medical’s technology to be used in big European heart study

NI Medical
MedCity News, October 19, 2010
NI Medical’s diagnostic device will be used in a far-ranging European Union-funded clinical study of heart disease and heart failure patients.

GCIC Brochure

September 2011 (320kb PDF)

Company Attraction Program

September 2010 (603kb PDF)

Company Attraction Program Application

August 2011 (168kb Microsoft Word document)

Global Cardiovascular Innovation Center